D.R. Horton (NYSE:DHI) Earns Underperform Rating from Wedbus

Wedbush reaffirmed their underperform rating on shares of D.R. Horton (NYSE:DHI – Free Report) in a research report sent to investors on Thursday, Benzinga reports. They currently have a $130.00 target price on the construction company’s stock. Wedbush also issued estimates for D.R. Horton’s Q3 2024 earnings at $3.62 EPS, Q4 2024 earnings at $3.93 […]

Related Keywords

United States , Hawaii , Hawaiian , Davidv Auld , Barbarak Allen , , Dr Horton Inc , Barclays , Finemark National Bank , Legal Advantage Investments Inc , Citigroup , First Hawaiian Bank , Securities Exchange Commission , Dr Horton Company Profile , Capital Advisors Inc , Wealthsource Partners , Free Report , Moderate Buy , Stock Down , Get Free Report , Exchange Commission , Director Barbara , Advantage Investments , Hawaiian Bank , Mark National Bank , South Central , Dr Horton , Nyse Dhi , Dhi , Construction , 23331a10 , Reiterated Rating , Wedbush ,